|
A unique course for advanced graduate students, postdocs, and independent investigators, who are seeking thorough training in modern approaches to the study of protozoan and helminthic parasites. Limited to 16 students.
The focus of this course is on the molecular basis of parasite function and the host/parasite interaction with special emphasis on the most recent and exciting developments in these areas. The course consists of daily lectures juxtaposed with intensive experimental work. About 40 invited speakers will give a lecture in their area of expertise and meet informally with students. These lectures will cover virtually all of the systems and areas of active research in modern parasitology. The laboratory portion of the course strikes a balance between ensuring that students acquire the technical expertise necessary to pursue these areas of research in their own careers while maintaining the element of the search for the unknown. Furthermore, the students will have the opportunity to work side-by-side at the benchtop with faculty recognized as leaders in their respective fields. The following areas are among those to be covered in the experimental portion of the course: (1) antigenic variation and cytoadherence in malaria; (2) drug design and development for treatment of trypanosomiasis and malaria; (3) immunology and pathogenesis of protozoan and filarial infections and (4) host:parasite interactions using Leishmania, Toxoplasma, and Trichomonas as model systems.
This course is supported by grants from the Burroughs Wellcome Fund, and Merck.
2008 Faculty and Lecturers:
Judith Allen, University of Edinburgh
David Artis, University of Pennsylvania
Yasmine Belkaid, NIH
Stephen Beverley, Washington University School of Medicine
John Boothroyd, Stanford University
W. Zacheus Cande, University of California, Berkeley
Frank Collins, University of Notre Dame
Kirk Deitsch, Weill Medical College of Cornell University
Dirk Dobbelaere, University of Bern
Mark Drew, Washington University, St. Louis
David Dunne, University of Cambridge
Paul Englund, Johns Hopkins Medical School
Stephen Hajduk, University of Georgia
Kent Hill, University of California, Los Angeles
Christopher Hunter, University of Pennsylvania
Jessica Kissinger, University of Georgia
Carole Long, NIAID/NIH
Andrew MacDonald, University of Edinburgh
Kai Matuschewski, Heidelberg University School of Medicine
James McKerrow, University of California, San Francisco
David Mirelman, Weizmann Institute of Science
Markus Mohrs, Trudeau Institute
Victor Nussenzweig, NYU School of Medicine
Margaret Phillips, UT Southwestern
Robert Sabatini, University of Georgia
Phillip Scott, University of Pennsylvania
David Sibley, Washington University School of Medicine
Steven Singer, Georgetown University
Upinder Singh, Stanford University
Dominique Soldati, University of Geneva
Boris Striepen, University of Georgia
Rick Tarleton, University of Georgia
Akhil Vaidya, Drexel University College of Medicine
Gary Ward, University of Vermont
Andy Waters, Glasgow University Dyann Wirth, Harvard School of Public Health
|
